Tel Aviv - Delayed Quote ILA

Nissan Medical Industries Ltd (NISA.TA)

Compare
1,292.00 -79.00 (-5.76%)
At close: December 19 at 5:24:19 PM GMT+2
Loading Chart for NISA.TA
DELL
  • Previous Close 1,371.00
  • Open 1,371.00
  • Bid 1,280.00 x 5000
  • Ask 1,292.00 x 12600
  • Day's Range 1,276.00 - 1,350.00
  • 52 Week Range 1,040.00 - 1,667.00
  • Volume 2,854
  • Avg. Volume 1,996
  • Market Cap (intraday) 117.359M
  • Beta (5Y Monthly) -0.31
  • PE Ratio (TTM) 6.21
  • EPS (TTM) 2.08
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 1, 2022
  • 1y Target Est --

Nissan Medical Industries Ltd, through its subsidiary, engages in the manufacturing and marketing of spunlace non-woven fabrics in the United States, Canada, Europe, and Israel. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.

395

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NISA.TA

View More

Performance Overview: NISA.TA

Trailing total returns as of 12/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NISA.TA
25.84%
TA-125
27.89%

1-Year Return

NISA.TA
19.74%
TA-125
29.64%

3-Year Return

NISA.TA
34.07%
TA-125
20.52%

5-Year Return

NISA.TA
7.43%
TA-125
48.49%

Compare To: NISA.TA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NISA.TA

View More

Valuation Measures

Annual
As of 12/19/2024
  • Market Cap

    118.81M

  • Enterprise Value

    286.61M

  • Trailing P/E

    6.29

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    0.48

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    3.53

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.67%

  • Return on Assets (ttm)

    6.14%

  • Return on Equity (ttm)

    10.60%

  • Revenue (ttm)

    729M

  • Net Income Avi to Common (ttm)

    19.45M

  • Diluted EPS (ttm)

    2.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.41M

  • Total Debt/Equity (mrq)

    48.78%

  • Levered Free Cash Flow (ttm)

    26.34M

Research Analysis: NISA.TA

View More

Company Insights: NISA.TA

Research Reports: NISA.TA

View More

People Also Watch